ClinicalTrials.Veeva

Menu

Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Enrolling

Conditions

Oncologic Complications and Emergencies

Treatments

Device: Introcan Safety IV Catheter

Study type

Interventional

Funder types

Other

Identifiers

NCT06217783
NCI-2024-00503 (Other Identifier)
2023-0848

Details and patient eligibility

About

To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.

Full description

Primary Objectives:

  • The rate of catheter failure, defined as removal of the catheter for any reason other than "Care Complete" (i.e. a composite of removal due to "infiltration," "leaking," "catheter damage," "occlusion"), by day 10.

Secondary Objectives:

  1. Time from catheter placement to removal (i.e. survival or dwell time).
  2. Per catheter length rate of failure analysis
  3. Rate of repeat catheterization
  4. Rate of infection
  5. Rate of thrombosis

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age > 18 years old.
  2. Provision of signed and dated informed consent form.
  3. Predetermined to have difficult IV access necessitating USIV placement
  4. Expected admission to hospital with anticipated stay > 48 hours (per discussion with treating physician).

Exclusion criteria

  1. Expected/anticipated discharge disposition from the ACCC (per discussion with treating physician).
  2. Inability to give informed consent.
  3. Pregnant women.
  4. Non-English speaking participants.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

400 participants in 2 patient groups

Group A
Experimental group
Description:
Participants will receive a catheter that is up to 1.75 inches long based on what the nurse thinks is best for you.
Treatment:
Device: Introcan Safety IV Catheter
Group B
Experimental group
Description:
Participants will receive a catheter that is either 1.75 or 2.5 inches long based on what the nurse thinks is best for you.
Treatment:
Device: Introcan Safety IV Catheter

Trial contacts and locations

1

Loading...

Central trial contact

Jonathan Rowland, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems